Inventor
Louis M. Staudt
Inventor
Bethesda, MD, US
Overview
Patents· 14 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C12Qprimary
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms30%
G01NInvestigating or analysing materials by determining their chemical or physical properties26%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations11%
G16BBioinformatics, i.e. information and communication technology [ict] specially adapted for genetic or protein-related data processing in computational molecular biology9%
C07KPeptides6%
C12NMicroorganisms or enzymes6%
Y02ATechnologies for adaptation to climate change6%
A61KPreparations for medical, dental or toiletry purposes2%
A61NElectrotherapy2%
C12YEnzymes2%
PatentTitleYear
11,028,444Survival predictor for diffuse large B cell lymphoma202110,697,975Methods for identifying, diagnosing, and predicting survival of lymphomas202010,607,717Method for subtyping lymphoma types by means of expression profiling202010,370,715Methods for identifying, diagnosing, and predicting survival of lymphomas20199,970,059Survival predictor for diffuse large B cell lymphoma20189,783,586'Inhibitors of the linear ubiquitin chain assembly complex (LUBAC) and related methods'20178,748,114'ZAP-70 expression as a marker for chronic lymphocytic leukemia / small lymphocytic lymphoma (CLL/SLL)'20148,131,475'Methods for identifying, diagnosing, and predicting survival of lymphomas'20127,981,610'ZAP-70 expression as a marker for chronic lymphocytic leukemia / small lymphocytic lymphoma (CLL/SLL)'20117,711,492'Methods for diagnosing lymphoma types'20107,329,502'ZAP-70 expression as a marker for chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL)'20086,410,516'Nuclear factors associated with transcriptional regulation'20026,150,090'Nuclear factors associated with transcriptional regulation'20005,804,374'Nuclear factors associates with transcriptional regulation'1998Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
1998–2002Based in Silver Springs, MD, US· patent location history
2008–2021Patents assigned to US HEALTH (11)· patent assignee history
2008–2014Based in Silver Spring, MD, US· patent location history
2012–2021Patents assigned to UNIV BARCELONA (5)· patent assignee history
2012–2021Patents assigned to UNIV NEBRASKA (5)· patent assignee history
2017–2021Based in Bethesda, MD, US· patent location history
2018–2021Patents assigned to BRITISH COLUMBIA CANCER AGENCY BRANCH (4)· patent assignee history
2018–2021Patents assigned to HOSPITAL CLINIC BARCELONA (4)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| US HEALTH | 11 | 2008–2021 |
| UNIV BARCELONA | 5 | 2012–2021 |
| UNIV NEBRASKA | 5 | 2012–2021 |
| BRITISH COLUMBIA CANCER AGENCY BRANCH | 4 | 2018–2021 |
| HOSPITAL CLINIC BARCELONA | 4 | 2018–2021 |
Locations
| Location | Patents | Span |
|---|---|---|
| Bethesda, Maryland, US | 6 | 2017–2021 |
| Silver Spring, Maryland, US | 5 | 2008–2014 |
| Silver Springs, Maryland, US | 3 | 1998–2002 |